Abstract
Considerable evidence supports the association between insulin resistance and vascular disease, and this has led to wide acceptance of the clustering of hyperlipidemia, glucose intolerance, hypertension, and obesity as a clinical entity, the metabolic syndrome. While insulin resistance, by promoting dyslipidemia and other metabolic abnormalities, is part of the proatherogenic milieu, it is possible that insulin resistance itself in the vascular wall does not promote atherosclerosis. Recent findings suggest that insulin resistance and atherosclerosis could represent independent and ultimately maladaptive responses to the disruption of cellular homeostasis caused by the excess delivery of fuel.
Keywords
Insulin resistanceDyslipidemiaHyperlipidemiaMetabolic syndromeInternal medicineMedicineInsulinEndocrinologyObesityDiabetes mellitus
Affiliated Institutions
Related Publications
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis...
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Many studies have shown that hyperinsulinemia and/or insulin resistance are related to various metabolic and physiological disorders including hypertension, dyslipidemia, and no...
Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study
Insulin resistance has been hypothesized to unify the clustering of hypertension, glucose intolerance, hyper-insulinemia, increased levels of triglyceride and decreased HDL chol...
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
The prevalence of insulin resistance in the most common metabolic disorders is still an undefined issue. We assessed the prevalence rates of insulin resistance in subjects with ...
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
Abstract Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor...
Publication Info
- Year
- 2006
- Type
- review
- Volume
- 116
- Issue
- 7
- Pages
- 1813-1822
- Citations
- 470
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
470
OpenAlex
Cite This
Clay F. Semenkovich
(2006).
Insulin resistance and atherosclerosis.
Journal of Clinical Investigation
, 116
(7)
, 1813-1822.
https://doi.org/10.1172/jci29024
Identifiers
- DOI
- 10.1172/jci29024